3CLpro |
3-Chymotrypsin-like protease |
ACE2 |
Angiotensin converting enzyme 2 |
ADALP1 |
Adenosine deaminase like protein 1 |
CES1 |
Carboxylesterase 1 |
COVID-19 |
Coronavirus infectious disease of 2019 |
CRM1 |
Chromosome region maintenance 1 |
ERGIC |
Endoplasmic reticulum–Golgi intermediate compartment |
GTP |
Guanosine triphosphate |
GUK1 |
Guanylate kinase 1 |
HINT1 |
Histidine triad nucleotide-binding protein 1 |
HBV |
Hepatitis B virus |
HCV |
Hepatitis C virus |
HIV |
Human immunodeficiency virus |
INF |
Interferon |
IL |
Interleukin |
MERS-CoV |
Middle East respiratory syndrome coronavirus |
Mpro
|
Main protease |
NDPK |
Nucleoside diphosphate kinase |
NSAIDs |
Nonsteroidal anti-inflammatory drugs |
NSP |
Nonstructural protein |
NF-AT |
Nuclear factor of activated T-cells |
mTOR |
Mammalian target of rapamycin |
PLpro |
Papain-like protease |
RdRp |
RNA-dependent RNA polymerase |
SARS-CoV |
Severe acute respiratory syndrome coronavirus |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus-2 |
TRMPSS2 |
Transmembrane protease serine 2 |